QWM
ARKG icon

Quadcap Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Quadcap Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,197
Closed -$207K – 385
2024
Q1 		$207K Sell
7,197
-271
-4% -$8.15K 0.05% 310
2023
Q4 		$245K Buy
+7,468
New +$203K 0.06% 285

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Quadcap Wealth Management's ARKG Position: Q2 2024 in Review

Quadcap Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 7,197 shares — an estimated $207K sold.

Quadcap Wealth Management first reported a position in ARKG in Q4 2023 and held it in 2 quarters. The position peaked at $245K in Q4 2023. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Quadcap Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Quadcap Wealth Management sold 7,197 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $207K.
  • Quadcap Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 2 quarters.
  • Quadcap Wealth Management's ARK Genomic Revolution ETF position peaked at $245K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Quadcap Wealth Management's 13F filing for Q2 2024, filed 14 Aug 2024.